SCHEMBL20748549

SCHEMBL20748549

Nc1ncnc2c1ncn2Cc1oc2ccc(Br)cc2c(=O)c1-c1ccc(F)c(Nc2ncnc3c2cnn3Cc2oc3ccc(Br)cc3c(=O)c2-c2ccccc2)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
NSD2 O96028 7/20 0.35
PRMT5 O14744 1/20 0.35
NSD3 Q9BZ95 1/20 0.35
ABL1 P00519 4/20 0.34
SRC P12931 3/20 0.34
MAPT P10636 3/20 0.34
HPGD P15428 2/20 0.34
ADORA2A P29274 1/20 0.34
PI4KA P42356 1/20 0.34
PI4K2B Q8TCG2 1/20 0.34
PI4K2A Q9BTU6 1/20 0.34
PI4KB Q9UBF8 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPK14 Q16539 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7930 0.83 ADORA2A (0.48) NSD2NSD3HPGDADORA2API4KA
SCHEMBL30670814 0.83 ADORA2A (0.48) NSD2NSD3HPGDADORA2API4KA
SCHEMBL8093 0.80 NSD2 (0.46) NSD2NSD3ADORA2API4KAPI4K2B
SCHEMBL30670884 0.80 NSD2 (0.46) NSD2NSD3ADORA2API4KAPI4K2B
SCHEMBL30694902 0.80 TBK1 (0.38) PRMT5ABL1SRCMAPTHPGD
SCHEMBL11533 0.80 TBK1 (0.38) PRMT5ABL1SRCMAPTHPGD
SCHEMBL30013159 0.77 ADORA2A (0.49) NSD2NSD3HPGDADORA2API4KA
SCHEMBL8903 0.77 ADORA2A (0.49) NSD2NSD3HPGDADORA2API4KA
SCHEMBL30670834 0.77 NSD2 (0.46) NSD2NSD3ADORA2API4KAPI4K2B
SCHEMBL8248 0.77 NSD2 (0.46) NSD2NSD3ADORA2API4KAPI4K2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3444242-A2 NOVEL BENZOPYRAN KINASE MODULATORS Rhizen Pharmaceuticals S.A. (CH) 2019-02-20 EP disclosed